黄文雯, 李辉章, 陈刚, 王实, 吴伟, 李雪, 杜灵彬, 程向东. 浙江省2019年至2021年上消化道癌机会性筛查结果分析[J]. 中国肿瘤临床, 2023, 50(7): 356-362. DOI: 10.12354/j.issn.1000-8179.2023.20221098
引用本文: 黄文雯, 李辉章, 陈刚, 王实, 吴伟, 李雪, 杜灵彬, 程向东. 浙江省2019年至2021年上消化道癌机会性筛查结果分析[J]. 中国肿瘤临床, 2023, 50(7): 356-362. DOI: 10.12354/j.issn.1000-8179.2023.20221098
Wenwen Huang, Huizhang Li, Gang Chen, Shi Wang, Wei Wu, Xue Li, Lingbin Du, Xiangdong Cheng. Analysis of opportunistic screening of upper gastrointestinal cancer in ZhejiangProvince in 2019-2021[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2023, 50(7): 356-362. DOI: 10.12354/j.issn.1000-8179.2023.20221098
Citation: Wenwen Huang, Huizhang Li, Gang Chen, Shi Wang, Wei Wu, Xue Li, Lingbin Du, Xiangdong Cheng. Analysis of opportunistic screening of upper gastrointestinal cancer in ZhejiangProvince in 2019-2021[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2023, 50(7): 356-362. DOI: 10.12354/j.issn.1000-8179.2023.20221098

浙江省2019年至2021年上消化道癌机会性筛查结果分析

Analysis of opportunistic screening of upper gastrointestinal cancer in ZhejiangProvince in 2019-2021

  • 摘要:
      目的  综合分析浙江省2019年至2021年上消化道癌机会性筛查结果,为上消化道癌机会性筛查及早诊早治工作的开展提供指导。
      方法  从国家项目数据管理平台导出浙江省2019年至2021年上消化道癌机会性筛查的资料,计算活检率、上消化道肿瘤性病变检出率、上消化道癌早诊率,采用χ2检验及趋势χ2检验比较不同组间率的差异。
      结果  2019年至2021年共247 055例受检者纳入上消化道癌机会性筛查,其中233 624例进行活检组织病理学检查。上消化道肿瘤性病变的检出率随年龄增加而上升(P<0.001),且男性显著高于女性 (均P<0.001)。在检出率的比较中,采用无痛胃镜组的上消化道肿瘤性病变检出率低于未采用无痛胃镜组,而采用染色组的高于未采用染色组,HP阳性组的高于HP阴性组(均P<0.001)。
      结论  严格依据国家推行的方案,可以扩大上消化道癌筛查和早诊早治覆盖范围,对于提高上消化道病变检出率具有重要意义,但仍需进一步普及癌症知识,提高上消化道癌早诊率。

     

    Abstract:
      Objective  To comprehensively analyze the results of opportunistic screening for upper gastrointestinal cancer in Zhejiang Province from 2019 to 2021, and to provide guidance for the development of opportunistic screening, early detection and treatment of upper GI cancer.
      Methods  The data of opportunistic screening of upper GI cancer in Zhejiang Province from 2019 to 2021 were derived from the national project data management platform; the biopsy rate; the detection rate of neoplastic lesions; and the calculated early diagnosis rate of upper GI cancer. The differences of the rates between the different groups were compared by χ2 tests and trend χ2 test.
      Results  A total of 247, 055 patients were included in opportunistic screening for upper GI cancer in 2019-2021, of which 233, 624 were biopsy histopathological examinations. It was found that the detection rate of upper GI neoplastic lesions increases with age (P<0.001) and is significantly higher in men than in women (P<0.001). In the comparison of detection rates, the detection rate of tumor lesions of upper GI cancer in the painless gastroscopy group was lower than that of the non-painless gastroscopy group, while the detection rate of tumor lesions of upper GI cancer in the staining group was higher than that of the non-stained group. The detection rate of tumor lesions of upper GI cancer in the HP-positive group was higher than that in the HP-negative group ( P<0.001).
      Conclusions  The results of this study confirmed that the coverage of upper GI cancer screening and early diagnosis and treatment can be expanded according to the national implementation plan, which is of great significance in improving the detection rate of upper GI cancer. However, it is still necessary to further improve the awareness rate of cancer knowledge and the early diagnosis rate of upper GI cancer in the population.

     

/

返回文章
返回